{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T03:24:49Z","timestamp":1649042689532},"reference-count":39,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.vaccine.2003.08.038","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T00:49:49Z","timestamp":1065833389000},"page":"689-696","source":"Crossref","is-referenced-by-count":10,"title":["Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis"],"prefix":"10.1016","volume":"22","author":[{"given":"Kevin D.","family":"Frick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Arantxa","family":"Colchero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.vaccine.2003.08.038_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/1120009X.2001.11782323","article-title":"Trachoma: a review","volume":"13","author":"Tabbara","year":"2001","journal-title":"J Chemother"},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.038_bib0010","first-page":"115","article-title":"Global data on blindness","volume":"73","author":"Thylefors","year":"1995","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2003.08.038_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00130920","article-title":"The global burden of trachomatous visual impairment. I. Assessing prevalence","volume":"19","author":"Ranson","year":"1995","journal-title":"Int Ophthalmol."},{"key":"10.1016\/j.vaccine.2003.08.038_bib0020","first-page":"473","article-title":"Vision and quality of life","volume":"97","author":"Brown","year":"1999","journal-title":"Trans Am Ophthalmol. Soc"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2003.08.038_bib0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1076\/opep.8.2.191.4163","article-title":"Epidemiological, demographic, and economic analyses: measurement of the value of trichiasis surgery in The Gambia","volume":"8","author":"Frick","year":"2001","journal-title":"Ophthalmic Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2003.08.038_bib0030","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/archopht.119.12.1839","article-title":"Trichiasis and disability in a trachoma-endemic area of Tanzania","volume":"119","author":"Frick","year":"2001","journal-title":"Arch Ophthalmol."},{"key":"10.1016\/j.vaccine.2003.08.038_bib0035","unstructured":"Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva, World Health Organization. WHO\/PBL\/GET\/97.1 (1997)."},{"key":"10.1016\/j.vaccine.2003.08.038_bib0040","unstructured":"Dean D. Pathogenesis of chlamydial ocular diseases. In: Tasman W, Jaeger EA, Chodosh J, editors. Duane\u2019s foundations of clinical ophthalmology, vol. 2. Philadelphia (PA). Lippincott; 2002. p. 1\u201320."},{"issue":"10","key":"10.1016\/j.vaccine.2003.08.038_bib0045","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/bjo.80.10.880","article-title":"Cost effectiveness and cost utility of preventing trachomatous visual impairment: lessons from 30 years of trachoma control in Burma","volume":"80","author":"Evans","year":"1996","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.038_bib0050","first-page":"201","article-title":"Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children","volume":"79","author":"Frick","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.038_bib0055","first-page":"150","article-title":"Strategies to control trachoma","volume":"8","author":"Schemann","year":"1998","journal-title":"Sante"},{"issue":"13","key":"10.1016\/j.vaccine.2003.08.038_bib0060","first-page":"4074","article-title":"Operational comparison of single-dose azithromycin and topical tetracycline for trachoma","volume":"41","author":"Bowman","year":"2000","journal-title":"Invest Ophthalmol. Vis Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.038_bib0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2307\/146268","article-title":"Private vaccination and public health: an empirical examination for US measles","volume":"31","author":"Philipson","year":"1995","journal-title":"J Hum Resour"},{"issue":"suppl 3","key":"10.1016\/j.vaccine.2003.08.038_bib0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00019053-199600093-00005","article-title":"Economic evaluation of vaccination","volume":"9","author":"Van Damme","year":"1996","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2003.08.038_bib0075","first-page":"55","article-title":"The epidemiology of trachoma predicts more blindness in the future","volume":"69","author":"Schachter","year":"1990","journal-title":"Scand J Infect Dis. Suppl"},{"key":"10.1016\/j.vaccine.2003.08.038_bib0080","unstructured":"Dean D. Trachoma. In: Connor DH, Schwartz DA, Chandler FW, editors. Pathology of infectious diseases. Stamford (CT): Appleton and Lange Publishers, 1997. p. 498\u2013507."},{"issue":"12","key":"10.1016\/j.vaccine.2003.08.038_bib0085","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bjo.80.12.1037","article-title":"Prevalence and risk factors for trachoma in Sarlahi district Nepal","volume":"80","author":"Katz","year":"1996","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.038_bib0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0161-6420(95)30997-9","article-title":"The epidemiology of trachoma in rural Kenya. Variation in prevalence with lifestyle and environment. Study Survey Group","volume":"102","author":"Schwab","year":"1995","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.vaccine.2003.08.038_bib0095","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-3156.1997.d01-211.x","article-title":"Trachoma in Jimma zone, south western Ethiopia","volume":"2","author":"Zerihun","year":"1997","journal-title":"Trop Med Int Health"},{"issue":"8","key":"10.1016\/j.vaccine.2003.08.038_bib0100","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/bjo.82.8.930","article-title":"Trachoma in The Gambia","volume":"82","author":"Dolin","year":"1998","journal-title":"Br. J. Ophthalmol."},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2003.08.038_bib0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1076\/opep.8.2.137.4158","article-title":"Progression of active trachoma to scarring in a cohort of Tanzanian children","volume":"8","author":"West","year":"2001","journal-title":"Ophthal. Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.038_bib0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1286-4579(01)01400-9","article-title":"Determinants of trachoma endemicity using Chlamydia trachomatis ompA DNA sequencing","volume":"3","author":"Hsieh","year":"2001","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.038_bib0115","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ije\/28.6.1167","article-title":"Incidence of trichiasis in a cohort of women with and without scarring","volume":"28","author":"Munoz","year":"1999","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.038_bib0120","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1034\/j.1600-0420.2000.078006703.x","article-title":"The cost of cataract patients awaiting surgery","volume":"78","author":"Stenevi","year":"2000","journal-title":"Acta Ophthalmol. Scand"},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.038_bib0125","first-page":"169","article-title":"Economic burden of blindness in India","volume":"46","author":"Shamanna","year":"1998","journal-title":"Ind J Ophthalmol."},{"issue":"4","key":"10.1016\/j.vaccine.2003.08.038_bib0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9394(02)02110-4","article-title":"The magnitude and cost of global blindness: an increasing problem that can be alleviated","volume":"135","author":"Frick","year":"2003","journal-title":"Am J Ophthalmol."},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.038_bib0135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/(SICI)1099-1050(199711)6:6<625::AID-HEC309>3.0.CO;2-O","article-title":"The interpretation of results of economic evaluation: explicating the value of health","volume":"6","author":"Ament","year":"1997","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.038_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C","article-title":"Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules","volume":"9","author":"Miller","year":"2000","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2003.08.038_bib0145","unstructured":"World Factbook (Washington, DC). Washington (DC): Central Intelligence Agency: Supt of Docs, U.S. G.P.O., 2002."},{"issue":"6","key":"10.1016\/j.vaccine.2003.08.038_bib0150","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0161-6420(03)00254-9","article-title":"Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states","volume":"110","author":"Brown","year":"2003","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.038_bib0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1076\/opep.10.2.121.13899","article-title":"Estimating the burden and economic impact of trachomatous visual loss","volume":"10","author":"Frick","year":"2003","journal-title":"Ophthal. Epidemiol"},{"key":"10.1016\/j.vaccine.2003.08.038_bib0160","unstructured":"Drummond MF, O\u2019Brien BJ, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. 2 ed. Oxford: Oxford University Press; 1997."},{"issue":"1","key":"10.1016\/j.vaccine.2003.08.038_bib0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ije\/31.1.194","article-title":"Risk factors for trachoma in Mali","volume":"31","author":"Schemann","year":"2002","journal-title":"Int J Epidemiol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.038_bib0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/aje\/152.3.204","article-title":"Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years","volume":"152","author":"Hsieh","year":"2000","journal-title":"Am J Epidemiol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.08.038_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hec.648","article-title":"A general model of the impact of absenteeism on employers and employees","volume":"11","author":"Pauly","year":"2002","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2003.08.038_bib0180","doi-asserted-by":"crossref","unstructured":"Dow WH, Holmes J, Philipson T, Sala-i-Martin X. Disease complementarities and the evaluation of public health interventions. National Bureau of Economic Research Working Paper no. w5216; 1995.","DOI":"10.3386\/w5216"},{"issue":"8","key":"10.1016\/j.vaccine.2003.08.038_bib0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-3156.2000.00603.x","article-title":"Review of the evidence base for the \u2018F\u2019 and \u2018E\u2019 components of the SAFE strategy for trachoma control","volume":"5","author":"Emerson","year":"2000","journal-title":"Trop Med Int Health."},{"issue":"2","key":"10.1016\/j.vaccine.2003.08.038_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1076\/opep.9.2.105.1522","article-title":"The flies and eyes project design and methods of a cluster-randomised intervention study to confirm the importance of flies as trachoma vectors in The Gambia and to test a sustainable method of fly control using pit latrines","volume":"9","author":"Emerson","year":"2002","journal-title":"Ophthal. Epidemiol."},{"key":"10.1016\/j.vaccine.2003.08.038_bib0195","unstructured":"Current trends in trachoma in a previously hyperendemic area. The Trachoma Study Group. Indian J Ophthalmol 1998;46(4):217\u201320."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03006443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T17:58:05Z","timestamp":1550685485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03006443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":39,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0264410X03006443"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.08.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}